Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coca-Cola
KO
|
+$443M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$300M |
| 3 |
Microsoft
MSFT
|
+$224M |
| 4 |
Amazon
AMZN
|
+$177M |
| 5 |
Walt Disney
DIS
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$356M |
| 2 |
Union Pacific
UNP
|
+$330M |
| 3 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$213M |
| 4 |
Automatic Data Processing
ADP
|
+$164M |
| 5 |
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
|
+$97.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.61% |
| 2 | Financials | 13.9% |
| 3 | Healthcare | 13% |
| 4 | Industrials | 10.42% |
| 5 | Consumer Discretionary | 10.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SAGE
776
DELISTED
Sage Therapeutics
SAGE
| $33.9M | 0.02% |
212,885
+26,278
| +14% | +$3.81M |
|
777
Darling Ingredients
DAR
$9.91B
| $33.9M | 0.02% |
1,563,895
+148,049
| +10% | +$3.12M |
|
|
AMED
778
DELISTED
Amedisys
AMED
| $33.8M | 0.02% |
274,309
+37,979
| +16% | +$4.77M |
|
|
ARRS
779
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $33.8M | 0.02% |
1,068,547
+74,906
| +8% | +$2.35M |
|
780
JD.com
JD
$45.2B
| $33.7M | 0.02% |
1,118,453
+224,081
| +25% | +$5.7M |
|
781
Cullen/Frost Bankers
CFR
$10.3B
| $33.6M | 0.02% |
346,487
+26,404
| +8% | +$2.62M |
|
|
CDK
782
DELISTED
CDK Global, Inc.
CDK
| $33.6M | 0.02% |
571,647
-128,103
| -18% | -$6.98M |
|
783
Sarepta Therapeutics
SRPT
$1.81B
| $33.5M | 0.02% |
281,477
+19,091
| +7% | +$2.45M |
|
784
Dell
DELL
$296B
| $33.5M | 0.02% |
1,125,997
+387,229
| +52% | +$10.2M |
|
785
Arch Capital
ACGL
$33.5B
| $33.5M | 0.02% |
1,036,135
+34,275
| +3% | +$1.04M |
|
786
VICI Properties
VICI
$28.7B
| $33.5M | 0.02% |
1,530,181
+226,402
| +17% | +$4.79M |
|
|
SGEN
787
DELISTED
Seagen Inc. Common Stock
SGEN
| $33.5M | 0.02% |
456,915
+30,026
| +7% | +$2.14M |
|
788
Spire
SR
$4.79B
| $33.5M | 0.02% |
406,598
+42,072
| +12% | +$3.28M |
|
789
Guidewire Software
GWRE
$14.4B
| $33.3M | 0.02% |
342,616
+19,699
| +6% | +$1.76M |
|
|
ARRY
790
DELISTED
Array Biopharma Inc
ARRY
| $33.3M | 0.02% |
1,364,811
+150,968
| +12% | +$3.14M |
|
791
Carlisle Companies
CSL
$15.3B
| $33.2M | 0.02% |
271,061
+9,264
| +4% | +$1.07M |
|
|
UMPQ
792
DELISTED
Umpqua Holdings Corp
UMPQ
| $33.1M | 0.02% |
2,006,232
+164,532
| +9% | +$2.9M |
|
793
Toro Company
TTC
$9.4B
| $33.1M | 0.02% |
480,325
-110,440
| -19% | -$7.01M |
|
794
Assured Guaranty
AGO
$3.34B
| $33M | 0.02% |
742,088
+44,852
| +6% | +$1.87M |
|
795
Service Corp International
SCI
$11.4B
| $33M | 0.02% |
821,083
+58,004
| +8% | +$2.42M |
|
|
GRA
796
DELISTED
W.R. Grace & Co.
GRA
| $32.8M | 0.02% |
420,579
+31,992
| +8% | +$2.36M |
|
797
Acadia Realty Trust
AKR
$2.78B
| $32.8M | 0.02% |
1,203,235
+53,696
| +5% | +$1.48M |
|
|
SAVE
798
DELISTED
Spirit Airlines, Inc.
SAVE
| $32.8M | 0.02% |
619,967
+33,092
| +6% | +$1.9M |
|
799
Essent Group
ESNT
$6.08B
| $32.7M | 0.02% |
752,649
+87,403
| +13% | +$3.6M |
|
800
SITE Centers
SITC
$158M
| $32.6M | 0.02% |
3,066,660
+149,855
| +5% | +$1.51M |
|
Similar funds
Charles Schwab's Q1 2019 Portfolio in Review
As of Q1 2019, Charles Schwab held 3,256 positions worth $156B, up 20% from $131B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Charles Schwab deployed $7.96B of net new capital in Q1 2019, opening 111 new positions and adding to 2,471 existing holdings. Its largest new stake was Fox Class A: 1,745,328 shares worth $64.1M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Walmart Inc, an estimated $356M trimmed.
- Charles Schwab's largest Q1 2019 buy was Fox Class A: 1,745,328 shares worth $64.1M.
- Charles Schwab added most to Coca-Cola in Q1 2019, an estimated $443M increase.
- Charles Schwab's biggest Q1 2019 reduction was Walmart Inc, cutting an estimated $356M.
- Charles Schwab fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $213M.
- Charles Schwab's ten largest holdings make up 14% of its $156B portfolio in Q1 2019.
- Charles Schwab opened 111 new positions and closed 64 in Q1 2019.
- Charles Schwab's portfolio value rose 20% quarter-over-quarter to $156B.
Based on Charles Schwab's 13F filing for Q1 2019, filed 14 May 2019.